Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co LtdfiledCriticalDainippon Pharmaceutical Co Ltd
Priority to FR7031684ApriorityCriticalpatent/FR2101154A1/fr
Publication of FR2101154A1publicationCriticalpatent/FR2101154A1/fr
Application grantedgrantedCritical
Publication of FR2101154B1publicationCriticalpatent/FR2101154B1/fr
C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
FR7031684A1970-07-311970-07-31Dehydrocorydaline salts for ulcer treatment
GrantedFR2101154A1
(en)